Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
544 ARTÍCULOS , VIENDO DEL 151 AL 165
Zhao Y, Bazan NG.
Curr Opin Clin Nutr Metab Care. 2026 Jul 1;29(4):421-430. doi: 10.1097/MCO.0000000000001223. Epub 2026 Mar 18.
Alameen AAM, Al-Kuraishy HM, Al-Gareeb AI, Shokr MM, Batiha GE.
Microvasc Res. 2026 Jul;166:104947. doi: 10.1016/j.mvr.2026.104947. Epub 2026 Mar 20.
The aging epigenome: integrative analyses reveal intersection with Alzheimer's disease
Zhang W, Lukacsovich D, Young JI, Gomez L, Schmidt MA, Kunkle BW, Chen X, Martin ER, Wang L; Alzheimer’s Disease Neuroimaging Initiative.
Geroscience. 2026 Jun;48(3):3185-3203. doi: 10.1007/s11357-026-02195-x. Epub 2026 Apr 14.
Path Integration in Alzheimer's Disease: Orientation, Movement, and Theta Rhythmicity
Castegnaro A, Kim M, Rudzka K, Burgess N.
Annu Rev Neurosci. 2026 Jul;49(1):451-470. doi: 10.1146/annurev-neuro-102124-020226. Epub 2026 Apr 16.
The effects of GLP-1 receptor agonists on Alzheimer's pathophysiology: A systematic review
Corcoran E, Kettlety M, Mogul U, Azah JN, Cork SC.
Mol Cell Neurosci. 2026 Jun;137:104091. doi: 10.1016/j.mcn.2026.104091. Epub 2026 Apr 20.
Progress and challenges in drug delivery for the treatment of Alzheimer's disease
Haghighi FH, Xie J, Ebert ET, Siahaan TJ.
Expert Opin Drug Deliv. 2026 Jul;23(7):1305-1327. doi: 10.1080/17425247.2026.2663114. Epub 2026 Apr 28.
Agavriloaei LM, Costachescu I, Szilagyi A, Gogu MR, Iliescu BF, Turliuc MD.
J Alzheimers Dis. 2026 Jun;111(4):1483-1498. doi: 10.1177/13872877261443555. Epub 2026 Apr 23.
Mitochondrial-nuclear crosstalk: A central axis in Alzheimer's disease
Samantaray K, Sinha A, Tomar D, Jadiya P.
Ageing Res Rev. 2026 Jul;119:103150. doi: 10.1016/j.arr.2026.103150. Epub 2026 Apr 25.
Serious side effects of Alzheimer's immunotherapy demand scrutiny
Høilund-Carlsen PF, Alavi A, Andalib S, Castellani RJ, Costa T, de Girolamo G, Espay AJ, Neve RL, Perry G, Revheim ME, Robakis NK, Sensi SL, Vissel B, Barrio JR.
Ageing Res Rev. 2026 Jul;119:103151. doi: 10.1016/j.arr.2026.103151. Epub 2026 Apr 27.
Tiny Titans, big promise: Nanotechnology and microRNA in the fight against Alzheimer's disease
Nakum B, Vejpara D, Faldu K, Soni R, Shah J.
Ageing Res Rev. 2026 Jul;119:103149. doi: 10.1016/j.arr.2026.103149. Epub 2026 Apr 27.
Yao Z, Godje ISG, Jiao B, Shen L, Luo S.
Ageing Res Rev. 2026 Jul;119:103153. doi: 10.1016/j.arr.2026.103153. Epub 2026 Apr 28.
Integrative role of orexigenic peptides in neuroprotection and neurodegenerative disease modulation
Sopko Z, Pačesová A, Železná B, Maletínská L.
Biosci Rep. 2026 Jul 22;46(7):BSR20250362. doi: 10.1042/BSR20250362.
Probiotics combat sarcopenia by restoring gut integrity in Alzheimer's disease
Qaisar R, Iqbal MS, Ahmad F, Karim A.
Explore (NY). 2026 Jul-Aug;22(4):103428. doi: 10.1016/j.explore.2026.103428. Epub 2026 Apr 24.
Choroid plexus volume in Alzheimer's disease: A systematic review and meta-analysis
Mahmoudi F, Yazdan Panah M, Dehghani Firouzabadi D, Vaheb S, Ghoshouni H, Flores Gonzalez R, Shaygannejad V, Mirmosayyeb O.
J Alzheimers Dis. 2026 Jul;112(1):53-64. doi: 10.1177/13872877261447404. Epub 2026 May 4.
RNA-based therapeutics for Alzheimer's disease and related tauopathies: challenges and opportunities
Rajbanshi B, Brentari I, Denti MA, Cummings JL, Guruacharya A.
J Prev Alzheimers Dis. 2026 Aug;13(7):100585. doi: 10.1016/j.tjpad.2026.100585. Epub 2026 May 7.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.